Sign in

CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Mineralys Therapeutics, Inc.

Sign in to watch
Ticker
MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
841966887
Phone
(888) 378-6240
Business address
150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,403,032
in 5 filings, $2.4M under 10b5-1 plans

Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Slingsby Brian Taylor −$3.0M Director sold 1% of stake
  2. Congleton Jon −$1.9M Chief Executive Officer sold 12% of stake
  3. Warren Eric −$402K Chief Commercial Officer sold 28% of stake
  4. Karydas Daphne −$86K Director sold 33% of stake

Reading 62 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-13 Rodman David Malcom Chief Medical Officer Option exercise 10b5-1 +3,542 $10.20 $36K 86,031
2026-03-13 Rodman David Malcom Chief Medical Officer Option exercise 10b5-1 +4,167 $14.25 $59K 90,198
2026-03-13 Rodman David Malcom Chief Medical Officer Sale 10b5-1 −10,726 $25.91 $278K 79,472
2026-03-13 Rodman David Malcom Chief Medical Officer Sale 10b5-1 −3,079 $27.37 $84K 76,393
2026-03-13 Rodman David Malcom Chief Medical Officer Sale 10b5-1 −253 $27.82 $7K 76,140
2026-03-13 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option 10b5-1 −3,542 123,959
2026-03-13 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option 10b5-1 −4,167 95,834
2026-03-12 Rodman David Malcom Chief Medical Officer Option exercise 10b5-1 +6,348 $1.08 $7K 88,837
2026-03-12 Rodman David Malcom Chief Medical Officer Sale 10b5-1 −6,348 $27.37 $174K 82,489
2026-03-12 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option 10b5-1 −6,348 25,395
2026-03-09 Rodman David Malcom Chief Medical Officer Option exercise 10b5-1 +2,171 $16.00 $35K 84,660
2026-03-09 Rodman David Malcom Chief Medical Officer Sale 10b5-1 −2,171 $26.84 $58K 82,489
2026-03-09 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option 10b5-1 −2,171 23,876
2026-02-19 Congleton Jon Chief Executive Officer Grant or award +140,900 780,051
2026-02-19 Congleton Jon Chief Executive Officer Grant or award · Stock Option +187,900 187,900
2026-02-19 SBLENDORIO GLENN Director Grant or award +6,200 6,200
2026-02-19 SBLENDORIO GLENN Director Grant or award · Stock Option +8,300 8,300
2026-02-19 Gold Alexander M Director Grant or award +6,200 6,200
2026-02-19 Gold Alexander M Director Grant or award · Stock Option +8,300 8,300
2026-02-19 Karydas Daphne Director Grant or award +6,200 6,200

Page 6 of 17 · 321 trades